NCT07712848
- Conditions
- AML (Acute Myeloid Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- The Second Affiliated Hospital of Kunming Medical University Kunming, Yunnan, China
Clinical trial condition
Hemic and Lymphatic Diseases
Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
21,120 public trials
3,997 recruiting studies
Hemic and Lymphatic Diseases trial results
- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06259292
- Conditions
- Arteriovenous Malformations, Brain Diseases, Cardiovascular Abnormalities, +35 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California, Los Angeles Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Colorado, Denver Aurora, Colorado, United States
NCT05429632
- Conditions
- Adult Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Alabama Hospital (UAB Hospital) Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- City of Hope Comprehensive Cancer Center - Duarte Duarte, California, United States
- University of California Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
NCT07039422
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
- Locations
-
- Novartis Investigative Site Buenos Aires, Argentina
- Novartis Investigative Site Roeselare, West-Vlaanderen, Belgium
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Dalian, Liaoning, China
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK012
NCT06565689
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
Recruiting
PregnAncy-Related Aortic DISsEction in China
NCT07672210
- Conditions
- Abnormalities, Multiple, Acute Aortic Syndrome, Aneurysm, +37 more
- Locations
-
- DeltaHealth Hospital Shanghai Shanghai, Shanghai Municipality, China
- Beijing Anzhen Hospital Beijing, China
- Guangdong Provincial Hospital Guangzhou, China
- Wuhan Union Hospital Wuhan, China
Recruiting
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
NCT06810778
- Conditions
- Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- David Geffen School of Medicine at the University of California at Los Angeles Los Angeles, California, United States
NCT06461988
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT05052528
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States